| Reduced lung-cancer mortality with low-dose computed tomographic screening National Lung Screening Trial Research Team New England Journal of Medicine 365 (5), 395-409, 2011 | 11258* | 2011 |
| Results of initial low-dose computed tomographic screening for lung cancer National Lung Screening Trial Research Team New England Journal of Medicine 368 (21), 1980-1991, 2013 | 1100 | 2013 |
| Cost-effectiveness of CT screening in the National Lung Screening Trial WC Black, IF Gareen, SS Soneji, JRD Sicks, EB Keeler, DR Aberle, ... New England Journal of Medicine 371 (19), 1793-1802, 2014 | 582 | 2014 |
| Results of the two incidence screenings in the National Lung Screening Trial DR Aberle, S DeMello, CD Berg, WC Black, B Brewer, TR Church, ... New England Journal of Medicine 369 (10), 920-931, 2013 | 577 | 2013 |
| National Institutes of Health consensus development conference statement: management of hepatitis B MF Sorrell, EA Belongia, J Costa, IF Gareen, JL Grem, JM Inadomi, ... Annals of internal medicine 150 (2), 104-110, 2009 | 534 | 2009 |
| Association of amyloid positron emission tomography with subsequent change in clinical management among medicare beneficiaries with mild cognitive impairment or dementia GD Rabinovici, C Gatsonis, C Apgar, K Chaudhary, I Gareen, L Hanna, ... Jama 321 (13), 1286-1294, 2019 | 449 | 2019 |
| Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the … BE Hillner, BA Siegel, D Liu, AF Shields, IF Gareen, L Hanna, SH Stine, ... Journal of Clinical Oncology 26 (13), 2155-2161, 2008 | 438 | 2008 |
| Failure of Macrolide Antibiotic Treatment in Patients with Bacteremia Due to Erythromycin-Resistant Streptococcus pneumoniae JR Lonks, J Garau, L Gomez, M Xercavins, AO de Echagüen, IF Gareen, ... Clinical Infectious Diseases 35 (5), 556-564, 2002 | 411 | 2002 |
| Comparison of abbreviated breast MRI vs digital breast tomosynthesis for breast cancer detection among women with dense breasts undergoing screening CE Comstock, C Gatsonis, GM Newstead, BS Snyder, IF Gareen, ... Jama 323 (8), 746-756, 2020 | 335 | 2020 |
| Baseline characteristics of participants in the randomized national lung screening trial National Lung Screening Trial Research Team Writing committee:, ... Journal of the National Cancer Institute 102 (23), 1771-1779, 2010 | 333 | 2010 |
| Lung cancer incidence and mortality with extended follow-up in the National Lung Screening Trial National Lung Screening Trial Research Team Journal of Thoracic Oncology 14 (10), 1732-1742, 2019 | 266 | 2019 |
| Relationship between cancer type and impact of PET and PET/CT on intended management: findings of the national oncologic PET registry BE Hillner, BA Siegel, AF Shields, D Liu, IF Gareen, E Hunt, RE Coleman Journal of Nuclear Medicine 49 (12), 1928-1935, 2008 | 253 | 2008 |
| Prognosis in infiltrating lobular carcinoma: an analysis of “classical” and variant tumors D DiCostanzo, PP Rosen, I Gareen, S Franklin, M Lesser The American journal of surgical pathology 14 (1), 12-23, 1990 | 195 | 1990 |
| Primary care provider-delivered smoking cessation interventions and smoking cessation among participants in the National Lung Screening Trial ER Park, IF Gareen, S Japuntich, I Lennes, K Hyland, S DeMello, ... JAMA internal medicine 175 (9), 1509-1516, 2015 | 184 | 2015 |
| Impact of lung cancer screening results on participant health‐related quality of life and state anxiety in the National Lung Screening Trial IF Gareen, F Duan, EM Greco, BS Snyder, PM Boiselle, ER Park, ... Cancer 120 (21), 3401-3409, 2014 | 171 | 2014 |
| The impact of positron emission tomography (PET) on expected management during cancer treatment: findings of the National Oncologic PET Registry BE Hillner, BA Siegel, AF Shields, D Liu, IF Gareen, L Hanna, SH Stine, ... Cancer 115 (2), 410-418, 2009 | 120 | 2009 |
| Risk perceptions among participants undergoing lung cancer screening: baseline results from the National Lung Screening Trial ER Park, JS Ostroff, W Rakowski, IF Gareen, MA Diefenbach, ... Annals of Behavioral Medicine 37 (3), 268-279, 2009 | 113 | 2009 |
| The restrictive IV fluid trial in severe sepsis and septic shock (RIFTS): a randomized pilot study KA Corl, M Prodromou, RC Merchant, I Gareen, S Marks, D Banerjee, ... Critical care medicine 47 (7), 951-959, 2019 | 105 | 2019 |
| The National Oncologic PET Registry (NOPR): design and analysis plan BE Hillner, D Liu, RE Coleman, AF Shields, IF Gareen, L Hanna, SH Stine, ... Journal of Nuclear Medicine 48 (11), 1901-1908, 2007 | 93 | 2007 |
| NIH consensus development statement on management of hepatitis B. EA Belongia, J Costa, IF Gareen, JL Grem, JM Inadomi, ER Kern, ... NIH consensus and state-of-the-science statements 25 (2), 1-29, 2008 | 83 | 2008 |
